Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Menthol in E-cigarettes on Smoking Behaviors
NCT04521647Phase 1Completed
- Sponsor
- Yale University
- Start
- May 2022
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine inhaler in nicotine dependence (2 arms), sponsored by Yale University. Primary endpoints: Plasma Nicotine Levels at 60 minutes and Nicotine Metabolic Rate at 60 minutes. Started May 2022; status: completed.
02
Drugs
nicotine inhaler
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04521647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521647.